- Home
- PHR
PHR
Phreesia Inc.
as 12-18-2024 1:07pm EST
Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
| Founded: | 2005 | Country: | United States |
| Employees: | 1438 | City: | WILMINGTON |
| Market Cap: | 1.4B | IPO Year: | 2019 |
| Target Price: | $29.38 | AVG Volume (30 days): | 443.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.07 - $29.16 | Next Earning Date: | 12-09-2024 |
| Revenue: | $405,137,000 | Revenue Growth: | 19.91% |
| Revenue Growth (this year): | 18.78% | Revenue Growth (next year): | 13.81% |
Stock Insider Trading Activity of Phreesia Inc. (PHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Weintraub Michael | PHR | Director | Dec 13 '24 | Sell | $25.15 | 21,426 | $536,790.22 | 242,827 | |
| Roberts Evan | PHR | Chief Operating Officer | Dec 10 '24 | Sell | $24.09 | 25,000 | $602,160.00 | 728,876 | |
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Dec 3 '24 | Sell | $20.93 | 25,447 | $532,559.91 | 93,470 | |
| Weintraub Michael | PHR | Director | Dec 2 '24 | Sell | $21.01 | 15,152 | $318,367.76 | 242,827 | |
| Linetsky David | PHR | SVP, Life Sciences | Oct 18 '24 | Sell | $20.49 | 1,100 | $22,539.00 | 200,207 | |
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Oct 15 '24 | Sell | $21.03 | 624 | $13,119.66 | 93,470 | |
| Roberts Evan | PHR | Chief Operating Officer | Oct 15 '24 | Sell | $21.03 | 1,843 | $38,749.26 | 728,876 | |
| Linetsky David | PHR | SVP, Life Sciences | Oct 15 '24 | Sell | $21.03 | 2,011 | $42,281.48 | 200,207 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Oct 15 '24 | Sell | $21.03 | 1,212 | $25,482.42 | 119,791 | |
| Indig Chaim | PHR | Chief Executive Officer | Oct 15 '24 | Sell | $21.03 | 3,089 | $64,946.53 | 1,220,647 |
Latest Phreesia Inc. News
PHR Breaking Stock News: Dive into PHR Ticker-Specific Updates for Smart Investing
MT Newswires
20 hours ago
Phreesia Insider Sold Shares Worth $536,790, According to a Recent SEC Filing
MT Newswires
5 days ago
Phreesia Insider Sold Shares Worth $294,559, According to a Recent SEC Filing
Simply Wall St.
6 days ago
Exploring Three High Growth Tech Stocks in the United States
TipRanks
6 days ago
Phreesia price target lowered to $30 from $34 at Baird
MT Newswires
7 days ago
Truist Raises Price Target on Phreesia to $34 From $31, Keeps Buy Rating
Simply Wall St.
7 days ago
Phreesia Third Quarter 2025 Earnings: EPS Beats Expectations
Thomson Reuters StreetEvents
8 days ago
Q3 2025 Phreesia Inc Earnings Call
GuruFocus.com
8 days ago
Phreesia Inc (PHR) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow
Compare PHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHR Phreesia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.